Versatile lyophilizer for research, development or small-scale production

15 May 2018

Allows for easy and intuitive scale-up from research.

The Genesis lyophilizer from SP Scientific has been designed with versatility in mind so that this freeze dryer can meet virtually any research, development or small-scale production lyophilization application.

Versatile lyophilizer for research, development or small-scale production

The Genesis is highly configurable and designed to deliver shelf temperatures as low as -70 °C, condenser temperatures to -85 °C, operate in bulk or stoppering configurations. Suitable applications include; pharmaceutical development, tissue processing and banking, natural products research and diagnostics reagent production.

Allowing for easy and intuitive scale-up from research, the Genesis makes the perfect mid-scale lyophilizer. The compact, free-standing, mobile design enables the system to be optimally configured to almost any application. Ergonomic profiling allows easy inspection of the vacuum pump and facilitates quick and trouble-free oil changes. For applications where a sterile environment is critical, an easy-to-install clean room version of the Genesis lyophilizer is also available.

The product chamber, shelves and condenser chamber are made of durable 316L stainless steel, with a squared product chamber that ensures easy cleaning and maximum shelf area. A 4-inch diameter port increases vapour flow from the product to the condenser chamber maximising system productivity. Reliable refrigeration systems with proven CFC-free refrigerants allow Genesis Lyophilizers to achieve a wide range of temperatures enabling freeze drying of all sample types.

The Genesis has a range of powerful control options which allow every aspect of the freeze-drying process to be monitored and controlled. Multiple stage freezing and drying steps can be programmed to enable the best results to be obtained from any product. Controls range from the simple Wizard microprocessor control system to a fully 21 CFR part 11 compliant PC-based control system.

The Genesis is available with up to six bulk drying shelves and five vial processing shelves. An expanded range of shelf arrangements, available with a shelf latching kit, allows you to configure it to process a wide variety of vial sizes, with stoppering an option.

Read More

Related news

Oxford Genetics signs major supply and licensing agreement for CRISPR engineered mammalian cell lines

Oxford Genetics signs major supply and licensing agreement for CRISPR engineered mammalian cell lines

8 Aug 2018

Company moves away from manual processing in favour of automated, scalable platforms.

Read more 
A new era for migraine patients

A new era for migraine patients

6 Aug 2018

EU approves Novartis's Aimovig, a first-of-its-kind treatment specifically designed for migraine prevention.

Read more 
WuXi STA and Antengene sign development and manufacturing agreement

WuXi STA and Antengene sign development and manufacturing agreement

24 Jul 2018

WuXi STA chosen for its end-to-end CMC platform for new drug development.

Read more 
ProBioGen and Pionyr initiate 2nd immuno-oncology contract development and manufacturing project

ProBioGen and Pionyr initiate 2nd immuno-oncology contract development and manufacturing project

18 Jul 2018

Parallel cell line development and analysis will allow for optimal cell line selection while compressing the development timeline.

Read more 
New screening company exploits the latest advances in microfluidics and 3D culture

New screening company exploits the latest advances in microfluidics and 3D culture

19 Jul 2018

The ability to micro size drug-cell interactions will allow pharmaceutical and biotech companies to do 100x more testing for the same money spent as well as increasing productivity.

Read more 
Natural lipid acts as potent anti-inflammatory

Natural lipid acts as potent anti-inflammatory

10 Jul 2018

Scientists see therapeutic potential against bacteria, viruses.

Read more 
Plasticell leads gene therapy manufacturing consortium

Plasticell leads gene therapy manufacturing consortium

3 Jul 2018

Consortium to develop advanced technologies for the manufacturing of ex vivo gene therapies.

Read more 
Follicum develops new direct-to-scalp formulation

Follicum develops new direct-to-scalp formulation

27 Jun 2018

The topical treatment for hair loss boasts a 'commercial' formulation.

Read more 
Collaboration to provide GMP-based services

Collaboration to provide GMP-based services

19 Jun 2018

Researchers to benefit by receiving a rapid and cost-effective scaled supply of new compounds.

Read more 
Locate Therapeutics secures £2 million to fast-track development of innovative cell therapy programs

Locate Therapeutics secures £2 million to fast-track development of innovative cell therapy programs

5 Jun 2018

TAOS matrix system and products hailed as potential ‘game changers’ in the field of regenerative medicine.

Read more